{"product_id":"ozempic","title":"OZEMPIC","description":"\u003cp dir=\"auto\" data-start=\"422\" data-end=\"621\" class=\"PDq2pG_selectionAnchorContainer\"\u003e\u003cstrong data-start=\"422\" data-end=\"445\"\u003eProduct Information\u003c\/strong\u003e\u003cbr data-start=\"445\" data-end=\"448\"\u003eOzempic® contains \u003cstrong data-start=\"466\" data-end=\"481\"\u003esemaglutide\u003c\/strong\u003e, a GLP-1 receptor agonist manufactured by Novo Nordisk. It is administered by subcutaneous injection and is used under medical supervision.\u003cspan class=\"PDq2pG_selectionAnchor\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" data-start=\"623\" data-end=\"647\"\u003e\u003cstrong data-start=\"623\" data-end=\"647\"\u003eApproved Indications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"648\" data-end=\"1179\"\u003e\n\u003cli data-start=\"648\" data-end=\"762\"\u003eAs an adjunct to diet and exercise to improve blood-glucose control in \u003cstrong data-start=\"721\" data-end=\"761\"\u003eadults with type 2 diabetes mellitus\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli data-start=\"763\" data-end=\"965\"\u003eTo reduce the risk of \u003cstrong data-start=\"787\" data-end=\"818\"\u003emajor cardiovascular events\u003c\/strong\u003e—including cardiovascular death, non-fatal heart attack, or non-fatal stroke—in adults with type 2 diabetes and established cardiovascular disease.\u003c\/li\u003e\n\u003cli data-start=\"966\" data-end=\"1179\"\u003eTo reduce the risk of \u003cstrong data-start=\"990\" data-end=\"1082\"\u003esustained decline in kidney function, end-stage kidney disease, and cardiovascular death\u003c\/strong\u003e in adults with type 2 diabetes and chronic kidney disease. \u003cspan class=\"contents\" data-content-reference-start=\"1137\" data-content-reference-end=\"1169\"\u003e\u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\" data-start=\"1181\" data-end=\"1208\"\u003e\u003cstrong data-start=\"1181\" data-end=\"1208\"\u003eKey Therapeutic Effects\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"1209\" data-end=\"1599\"\u003e\n\u003cli data-start=\"1209\" data-end=\"1311\"\u003eHelps improve glycemic control in adults with type 2 diabetes when used alongside diet and exercise.\u003c\/li\u003e\n\u003cli data-start=\"1312\" data-end=\"1442\"\u003eProvides cardiovascular risk reduction for the indicated population with type 2 diabetes and established cardiovascular disease.\u003c\/li\u003e\n\u003cli data-start=\"1443\" data-end=\"1599\"\u003eProvides kidney-related risk reduction for the indicated population with type 2 diabetes and chronic kidney disease. \u003cspan class=\"contents\" data-content-reference-start=\"1552\" data-content-reference-end=\"1571\"\u003e\u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\" data-start=\"1601\" data-end=\"1620\"\u003e\u003cstrong data-start=\"1601\" data-end=\"1620\"\u003eProduct Details\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul data-start=\"1621\" data-end=\"2040\"\u003e\n\u003cli data-start=\"1621\" data-end=\"1642\"\u003e\n\u003cstrong data-start=\"1623\" data-end=\"1633\"\u003eBrand:\u003c\/strong\u003e Ozempic®\u003c\/li\u003e\n\u003cli data-start=\"1643\" data-end=\"1679\"\u003e\n\u003cstrong data-start=\"1645\" data-end=\"1667\"\u003eActive ingredient:\u003c\/strong\u003e Semaglutide\u003c\/li\u003e\n\u003cli data-start=\"1680\" data-end=\"1712\"\u003e\n\u003cstrong data-start=\"1682\" data-end=\"1699\"\u003eManufacturer:\u003c\/strong\u003e Novo Nordisk\u003c\/li\u003e\n\u003cli data-start=\"1713\" data-end=\"1753\"\u003e\n\u003cstrong data-start=\"1715\" data-end=\"1730\"\u003eDrug class:\u003c\/strong\u003e GLP-1 receptor agonist\u003c\/li\u003e\n\u003cli data-start=\"1754\" data-end=\"1808\"\u003e\n\u003cstrong data-start=\"1756\" data-end=\"1772\"\u003eDosage form:\u003c\/strong\u003e Solution for subcutaneous injection\u003c\/li\u003e\n\u003cli data-start=\"1809\" data-end=\"1842\"\u003e\n\u003cstrong data-start=\"1811\" data-end=\"1830\"\u003eAdministration:\u003c\/strong\u003e Once weekly\u003c\/li\u003e\n\u003cli data-start=\"1843\" data-end=\"1991\"\u003e\n\u003cstrong data-start=\"1845\" data-end=\"1869\"\u003eAvailable strengths:\u003c\/strong\u003e 0.5mg\u003c\/li\u003e\n\u003cli data-start=\"1992\" data-end=\"2040\"\u003e\n\u003cstrong data-start=\"1994\" data-end=\"2018\"\u003ePrescription status:\u003c\/strong\u003e Prescription medicine\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp dir=\"auto\" data-start=\"2042\" data-end=\"2521\"\u003e\u003cstrong data-start=\"2042\" data-end=\"2074\"\u003eImportant Safety Information\u003c\/strong\u003e\u003cbr data-start=\"2074\" data-end=\"2077\"\u003eOzempic carries important warnings and contraindications. It is contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC), people with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), and people with serious hypersensitivity to semaglutide or its ingredients. Reported common adverse reactions include nausea, vomiting, diarrhea, abdominal pain, and constipation.\u003c\/p\u003e","brand":"brunodermalfiller.com","offers":[{"title":"Default Title","offer_id":50431337988353,"sku":null,"price":150.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0617\/7062\/9377\/files\/Ozempic-Semaglutide-Injection-0.25-mg-by-Novo-Nordisk-NDC-00169-4181-13_491d186a-803e-4d03-8242-1f7c825e6e6e.webp?v=1790786310","url":"https:\/\/brunodermalfiller.com\/en-pt\/products\/ozempic","provider":"brunodermalfiller.com","version":"1.0","type":"link"}